DFTX
Definium Therapeutics, Inc.
36.70$
-2.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -30.5% | +1,886.4% | -12.3% | -16.9% | +2,675.7% | +101.2% | +3.7% | -26.7% | +142.6% | +45.7% | |
| – | -26.9% | +1,201.0% | -88.8% | +1,378.6% | +2,675.7% | +68.3% | +6.4% | -28.9% | +171.1% | +48.9% | |
| – | +137.2% | -63.7% | +3,791.5% | -88.4% | +446,578.9% | +66.7% | +6.4% | -29.9% | +174.6% | -5.8% | |
| – | -29.7% | +1,207.4% | -90.8% | -88.4% | +446,578.9% | +66.7% | +6.4% | -29.9% | +174.6% | +50.4% | |
| – | +1,260.6% | +110.7% | -19.8% | -38.4% | – | – | – | – | – | – | |
| – | -244.1% | – | – | -101.1% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | -46.3% | -85.7% | – | – | |
| – | +908.3% | +6.6% | -89.8% | +2,317.6% | +2,740.3% | +118.3% | +54.6% | +143.3% | +30.8% | +77.5% | |
| – | +908.3% | +6.6% | -89.8% | +2,317.6% | +1,411.9% | +246.0% | +71.9% | +80.2% | +20.5% | +71.7% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +106.6% | -49.5% | +95.9% | -51.4% | +166.0% | |
| – | – | – | – | – | – | – | – | – | +54.7% | +85.7% | |
| – | -55.2% | +3,001.1% | -10.7% | -22.3% | +2,671.0% | +99.9% | -0.5% | -48.2% | +209.0% | +37.6% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.8% | +214.4% | +23.6% | +21.4% | +4,577.8% | +54.3% | +12.7% | +26.9% | +1,699.4% | -87.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.